Biomolecules expertise

BIOSIMILAR REVIEW

VelaLabs’ expertise covers a variety of biomolecules including biosimilars. The Biosimilar Review shows a market overview and can be downloaded free of charge below.

Read the review now

FACT SHEETS

These fact sheets will show you VelaLab's analytical portfolio in the area of biomolecules.

You will also get information about the mode of action, patent status, market, originator and research status of these selected biosimilars, antibodies, mabs and hormones:

 

COMPETITIVE REPORT:

As we know the market, we have a competitive field available for all of these biomolecules:

the competitive fields are researched with state-of-the-art methods and are routinely updated.

These analysis are available upon request - see an example for a competitive field for adalimumab in our Biosimilar Review

Biosimilars approved - USA & EU

Table 1: Biosimilars approved in USA

Product name Manufacturer
Adalimumab (launch delayed until 2023)
Amjevita® Amgen
Cyltezo® Boehringer Ingelheim
Hadlima® Samsung Bioepis, Biogen
Hyrimoz® Sandoz
Abrilada® Pfizer
Yusimry® Coherus
Yuflyma® Celltrion
Bevacizumab
Mvasi® Amgen, Allergan
Zirabev® Pfizer
Alymsys® Amneal Pharmaceuticals
Vegzelma® Celltrion
Epoetin alfa
Retacrit® Pfizer, Hospira
Etanercept
Erelzi® Sandoz
Eticovo® Samsung Bioepis, Merck
Filgrastim
Nivestym® Pfizer
Zarxio® Sandoz
Releuko® Amneal Pharmaceuticals / Kashiv Biosciences
Infliximab
Inflectra® Pfizer, Hospira
Ixifi® Pfizer (not launched)
Renflexis® Samsung Bioepis
Avsola® Amgen
Insulin
Admelog® Sanofi
Basaglar® Eli Lilly, Boehringer Ingelheim
Rezvoglar® Eli Lilly
Semglee® Mylan, USA / Biocon, India
Pegfilgrastim
Fulphila® Biocon, Mylan
Udenyca® Coherus
Ziextenzo® Sandoz
Nyvepria® Pfizer
Fylnetra™ Amneal Pharmaceuticals / Kashiv
Stimufend® Fresenius Kabi
Ranibizumab
Byooviz® Samsung Bioepis / Biogen
Cimerli® Formycon / Bioeq
Rituximab
Truxima® Celltrion
Ruxiene® Pfizer
Riabni® Amgen
Trastuzumab
Ogivri® Biocon, Mylan
Ontruzant® Samsung Bioepis / Merck
Herzuma® Celltrion / Teva
Trazimera® Pfizer
Kanjinti® Amgen

Table 2: Biosimilars approved in EU

Product name Manufacturer
Adalimumab
Amgevita®

Solymbic®

Amgen
Cyltezo® Boehringer Ingelheim
(not marketed)
Imraldi® Samsung Bioepis
Halimatoz® / Hefya® / Hyrimoz® Sandoz
Hulio® Mylan
Idacio® / Kromeya® Fresenius Kabi
Amsparity® Pfizer
Hukyndra® / Libmyris® Alvotech
Yuflima® Celltrion
Aflibercept
Yesafili® Biocon
Bevacizumab
Mvasi® Amgen
Zirabev® Pfizer
Aybintio® / Onbevzi® Samsung Bioepis
Alymsys® mAbxience
Oyavas® Stada Arzneimittel
Abevmy® / Lextemy® Mylan (now Viatris); collaboration with Biocon
Vegzelma Celltrion
Eculizumab
Bekemv® Amgen
Epysqli® Samsung Bioepis
Epoetin
Abseamed® Medice Arzneimittel Pütter
Epoetin alfa Hexal® Hexal
Binocrit® Sandoz
Retacrit® Hospira
Silapo® Stada Arzneimittel
Etanercept
Benepali® Samsung Bioepis
Erelzi® Sandoz
Nepexto® Mylan
Filgrastim
Accofil® Accord Healthcare
Biograstim® CT Arzneimittel
Filgrastim Hexal® Hexal
Filgrastim Ratiopharm®

Ratiograstim®

Ratiopharm
Grastofil® Apotex
Nivestim® Hospira / Pfizer
Tevagrastim® Teva
Zarzio® Sandoz
Follitropin alfa
Bemfola® Finox Biotech
Ovaleap® Teva
Infliximab
Flixabi® Samsung Bioepis
Inflectra® Hospira
Remsima® Celltrion
Zessly® Sandoz
Insulin
Abasaglar® Eli Lilly, Boehringer
Ingelheim
Insulin lispro® Sanofi
Lusduna® MSD
Semglee® Mylan
Insulin Aspart Sanofi
Kixelle® (Insulin aspart) Mylan
Pegfilgrastim
Pelgraz® Accord Healthcare (Intas)
Udenyca® Coherus
Fulphila® Biocon / Mylan
Pelmeg® Cinfa / Mundipharma
Cegfila® Mundipharma
Ziextenzo® Sandoz
Grasustek™ Juta Pharma/ USV
Stimufend® Fresenius Kabi
Ranibizumab
Byooviz® Samsung Bioepis / Biogen
Ranivisio® Formycon / Polpharma
Ximluci® Stada Arzneimittel / Xbrane
Rituximab
Blitzima®

Ritemvia®

Rituzena®

Truxima®

Celltrion
Rixathon®

Riximyo®

Sandoz
Somatropin
Omnitrope® Sandoz
Teriparatide
Movymia® Stada Arzneimittel
Terrosa® Gedeon Richter
Livogiva® Theramex
Qutavina® EuroGenerix
Sondelbay® Accord Healthcare
Trastuzumab
Herzuma® Celltrion
Ontruzant® Samsung Bioepis
Kanjinti® Amgen
Trazimera® Pfizer
Ogivri® Mylan
Zercepac® Shanghai Henlius / Accord Healthcare
We Value Your Privacy
We use cookies on our website. Some of them are essential, while others help us to analyze how this website is being used and to allow you to contact us through our website, i.e. use the chat widget. You can change your decision at any time.
We Value Your Privacy
Statistics
We use these technologies to analyze how this website is being used.
Name Google Analytics, Google Tag Manager
Provider Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland
Purpose Cookie by Google used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy Policy https://policies.google.com/privacy
Cookie Name _ga, _gat, _gid
Cookie Expiry 2 years

 

Name LinkedIn Corporation
Provider LinkedIn Corporation, 605 W Maude Ave, Sunnyvale, CA 94085, USA
Purpose Cookie by LinkedIn used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy Policy https://www.linkedin.com/legal/privacy-policy
Cookie Name
Cookie Expiry 2 years
Customer Interaction
These technologies will allow you to contact us through our website, i.e. use the chat widget.
Name LiveChat
Provider LiveChat Software S.A., ul. Zwycięska 47, 53-033 Wroclaw, Poland
Purpose Communication with clients via online chat using the API of the chat service LiveChat.
Privacy Policy https://www.livechat.com/legal/privacy-policy/
Cookie Name __lc_cid, __lc_cst
Cookie Expiry 2 years
Essential
Technologies required to enable the core functionality of this website.
Name Cookie Consent
Provider Owner of this website, Imprint
Purpose Saves the visitors preferences selected in the cookie banner.
Cookie Name ws_cookie_consent
Cookie Expiry 1 year